MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
MetLife, Inc.NYSE: MET
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue grows in line with its trailing trend
Q2 FY2026 revenue of $18.88B rose 9.9% year over year, ahead of the +9.0% change in trailing-twelve-month revenue. Sequentially, it fell 1.0% from the prior quarter. Over 3 fiscal years it compounded at +4.3% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 6 analysts of $79.37B (+3.0%) for the fiscal year ending Dec 2026, a slowdown from the +10.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $18.88B-1.0% QoQ
- Last fiscal yearDec 2025
- $77.08B+10.2% YoY
- LTMJun 2026
- $78.65B+9.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +9.9% | +17.6% | +7.7 pp |
| 1 year | +10.2% | +3.0% | -7.3 pp |
| 3-year CAGR | +4.3% | +4.1% | -0.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 77.08B USD
- Year-over-year change
- +10.2%
- 4-year CAGR
- +5.0%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 77.08B | +10.2% |
| FY2024 | 2024-12-31 | 69.94B | +3.3% |
| FY2023 | 2023-12-31 | 67.71B | -0.4% |
| FY2022 | 2022-12-31 | 67.97B | +7.3% |
| FY2021 | 2021-12-31 | 63.37B | — |
Revenue vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +9.0% is the 2nd highest of 11, against a peer median of +5.9%.
- Over three fiscal years its annual growth of +4.3% compares with a peer median of +4.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $78.65B USD | +9.0% | +4.3% | |
| LTM Jun 2026 | $64.83B USD | +8.9% | +2.3% | |
| LTM Jun 2026 | CA$57.93B CAD | -16.0% | +29.9% | |
| LTM Jun 2026 | $19.36B USD | +7.2% | -1.3% | |
| LTM Jun 2026 | $18.09B USD | +11.6% | -3.1% | |
| LTM Jun 2026 | $13.25B USD | +3.3% | +3.2% | |
| LTM Sep 2026 | $6.28B USD | +5.7% | +4.7% | |
| LTM Sep 2026 | $5.43B USD | -7.9% | -2.2% | |
| LTM Jun 2026 | $4.65B USD | +6.0% | +7.9% | |
| LTM Jun 2026 | $3.77B USD | -5.0% | +8.1% | |
| LTM Sep 2026 | $3.46B USD | +7.3% | +6.7% | |
| Peer median (excluding MET) | — | +5.9% | +4.0% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.